Intracranial Hemorrhage

被引:42
作者
Naidech, Andrew M. [1 ]
机构
[1] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
intracranial hemorrhage; cerebral hemorrhage; subarachnoid hemorrhage; outcomes; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ACUTE INTRACEREBRAL HEMORRHAGE; ACUTE ISCHEMIC-STROKE; INTENSIVE-CARE-UNIT; ACUTE LIVER-FAILURE; ORAL ANTICOAGULANT-THERAPY; PLACEBO-CONTROLLED TRIAL; ACTIVATED FACTOR-VII; CEREBRAL-BLOOD-FLOW; RISK-FACTORS;
D O I
10.1164/rccm.201103-0475CI
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Intracranial hemorrhageis a life-threatening condition, the outcome of which can be improved by intensive care. Intracranial hemorrhage may be spontaneous, precipitated by an underlying vascular malformation, induced by trauma, or related to therapeutic anticoagulation. The goals of critical care are to assess the proximate cause, minimize the risks of hemorrhage expansion through blood pressure control and correction of coagulopathy, and obliterate vascular lesions with a high risk of acute rebleeding. Simple bedside scales and interpretation of computed tomography scans assess the severity of neurological injury. Myocardial stunning and pulmonary edema related to neurological injury should be anticipated, and can usually be managed. Fever (often not from infection) iscommonand can be effectively treated, although therapeutic cooling has not been shown to improve outcomes after intracranial hemorrhage. Most functional and cognitive recovery takes place weeks to months after discharge; expected levels of functional independence (no disability, disability but independence with a device, dependence) may guide conversations with patient representatives. Goals of care impact mortality, with do-not-resuscitate status increasing the predicted mortality for any level of severity of intraparenchymal hemorrhage. Future directions include refining the use of bedside neuromonitoring (electroencephalogram, invasive monitors), novel approaches to reduce intracranial hemorrhage expansion, minimizing vasospasm, and refining the assessment of quality of life to guide rehabilitation and therapy.
引用
收藏
页码:998 / 1006
页数:9
相关论文
共 116 条
  • [31] The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial
    den Hertog, Heleen M.
    van der Worp, H. Bart
    van Gemert, H. Maarten A.
    Algra, Ate
    Kappelle, L. Jaap
    Van Gijn, Jan
    Koudstaal, Peter J.
    Dippel, Diederik W. J.
    [J]. LANCET NEUROLOGY, 2009, 8 (05) : 434 - 440
  • [32] Dennis L J, 2001, Neurol India, V49 Suppl 1, pS37
  • [33] Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator
    Derex, L
    Hermier, M
    Adeleine, P
    Pialat, JB
    Wiart, M
    Berthezène, Y
    Philippeau, F
    Honnorat, J
    Froment, JC
    Trouillas, P
    Nighoghossian, N
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (01) : 70 - 75
  • [34] Red Blood Cell Transfusion Increases Cerebral Oxygen Delivery in Anemic Patients With Subarachnoid Hemorrhage
    Dhar, Rajat
    Zazulia, Allyson R.
    Videen, Tom O.
    Zipfel, Gregory J.
    Derdeyn, Colin P.
    Diringer, Michael N.
    [J]. STROKE, 2009, 40 (09) : 3039 - 3044
  • [35] Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset
    Diedler, Jennifer
    Ahmed, Niaz
    Sykora, Marek
    Uyttenboogaart, Maarten
    Overgaard, Karsten
    Luijckx, Gert-Jan
    Soinne, Lauri
    Ford, Gary A.
    Lees, Kennedy R.
    Wahlgren, Nils
    Ringleb, Peter
    [J]. STROKE, 2010, 41 (02) : 288 - 294
  • [36] Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system
    Diringer, MN
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (02) : 559 - 564
  • [37] Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
    Ehrenreich, Hannelore
    Weissenborn, Karin
    Prange, Hilmar
    Schneider, Dietmar
    Weimar, Christian
    Wartenberg, Katja
    Schellinger, Peter D.
    Bohn, Matthias
    Becker, Harald
    Wegrzyn, Martin
    Jaehnig, Peter
    Herrmann, Manfred
    Knauth, Michael
    Baehr, Mathias
    Heide, Wolfgang
    Wagner, Armin
    Schwab, Stefan
    Reichmann, Heinz
    Schwendemann, Guenther
    Dengler, Reinhard
    Kastrup, Andreas
    Bartels, Claudia
    [J]. STROKE, 2009, 40 (12) : E647 - E656
  • [38] Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical
    Ellis, AJ
    Wendon, JA
    Williams, R
    [J]. HEPATOLOGY, 2000, 32 (03) : 536 - 541
  • [39] Fever after subarachnoid hemorrhage - Risk factors and impact on outcome
    Fernandez, A.
    Schmidt, J. M.
    Claassen, J.
    Pavlicova, M.
    Huddleston, D.
    Kreiter, K. T.
    Ostapkovich, N. D.
    Kowalski, R. G.
    Parra, A.
    Connolly, E. Sander
    Mayer, S. A.
    [J]. NEUROLOGY, 2007, 68 (13) : 1013 - 1019
  • [40] Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
    Flibotte, JJ
    Hagan, N
    O'Donnell, J
    Greenberg, SM
    Rosand, J
    [J]. NEUROLOGY, 2004, 63 (06) : 1059 - 1064